News Sentiment

CVRX sentiment intelligence

CVRx Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 36 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 5.43 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

78/100 classification confidence.

Company focus 25

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.0% over one week, +8.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 78/100 classification
One-week reaction -3.0% Price reacting lower
Trend fit Trend inactive 8.0% over four weeks
Fair value -54.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 27
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 25
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 7
Moomoo 4
TradingKey 4
AD HOC NEWS 2
StockStory 2
Stock Traders Daily 1
Finviz 1

Event Lens

What the news is about

Classified themes
Earnings 20
Market update 13
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 36
AD HOC NEWS Direct company coverage

CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing

CVRx Inc, listed on Nasdaq, specializes in developing neurostimulation devices like Barostim for patients with heart failure and hypertension whose symptoms are difficult to control with conventional therapies. The company's business model relies on partnerships with cardiologist

Tone
Positive 68/100
Event
Market update
Published
08 Jul 2026 17:09
Source
AD HOC NEWS
Moomoo Direct company coverage

CVRx Inc(CVRX) Stock Options Chain | Quotes & News

This article provides access to the stock options chain, quotes, and news for CVRx Inc (CVRX). It serves as a financial information resource for investors interested in the company's stock performance and related options data.

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 02:09
Source
Moomoo
AD HOC NEWS Direct company coverage

CVRx Inc focuses on cardiovascular innovation amid thin market signals

CVRx Inc, a US medical technology company, specializes in neuromodulation therapies for chronic heart failure and hypertension, targeting patients whose conditions are not controlled by conventional treatments. The company develops implantable systems, such as those for barorefle

Tone
Positive 67/100
Event
Market update
Published
07 Jul 2026 21:33
Source
AD HOC NEWS
Moomoo Direct company coverage

Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14

Lake Street has reiterated its Buy rating for CVRx Inc (CVRX.US) and maintained its target price of $14. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and valuation. The report suggests confidence in CVRx Inc's future

Tone
Positive 75/100
Event
Analyst action
Published
07 Jul 2026 02:39
Source
Moomoo
Stock Traders Daily Direct company coverage

(CVRX) Risk Channels and Responsive Allocation

This article analyzes Cvrx Inc. (NASDAQ: CVRX) using AI models, identifying a mixed sentiment alignment and a mid-channel oscillation pattern. It highlights an exceptional short setup with a 91.5:1 risk-reward ratio, targeting a 28.1% downside. The analysis provides specific trad

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 17:14
Source
Stock Traders Daily
TradingView Direct company coverage

Enterprise value to EBIT forward of CVRx, Inc. – NASDAQ:CVRX

The article focuses on the enterprise value to EBIT forward for CVRx, Inc. (NASDAQ: CVRX). It presents a snapshot of the company's financial data on TradingView, indicating that the market is closed at the time of viewing. The content primarily highlights where to find this finan

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 01:39
Source
TradingView
Finviz Direct company coverage

CVRX,INVA Volatility & Greeks

This article provides a detailed financial overview of two companies, CVRx Inc. (CVRX) and Innoviva Inc. (INVA), including their stock performance, market capitalization, key financial ratios, and analyst recommendations. It lists various metrics such as volatility, EPS, sales gr

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 12:13
Source
Finviz
TradingView Direct company coverage

Enterprise value to revenue forward of CVRx, Inc. – NASDAQ:CVRX

The article presents information regarding the enterprise value to forward revenue for CVRx, Inc. (NASDAQ: CVRX). It is a finance-related snippet from TradingView, focusing on the company's financials within the health technology sector. The content appears to be a stub or a sect

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 22:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of CVRx, Inc. – NASDAQ:CVRX

The article provides information regarding the forward price-to-earnings ratio for CVRx, Inc. (NASDAQ: CVRX) within the TradingView platform. It shows the navigation path to access this financial data and emphasizes that the market was closed with no trades at the time of viewing

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 14:40
Source
TradingView
TradingView Direct company coverage

Price to book forward of CVRx, Inc. – NASDAQ:CVRX

This article displays information regarding the "Price to book forward" metric for CVRx, Inc. (NASDAQ: CVRX) on TradingView. It indicates that the data is provided by human input and is available in English. The page is part of TradingView's financial data section for CVRx, Inc.

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 04:40
Source
TradingView
TradingView Direct company coverage

CVRx, Inc. Actuals & Estimates (NASDAQ:CVRX)

This article provides an overview of CVRx, Inc. (NASDAQ:CVRX) stock performance, financial actuals, and analyst estimates. It highlights the current stock price, recent changes, market capitalization, and future earnings expectations, along with historical data like all-time high

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 19:40
Source
TradingView
TradingKey Direct company coverage

CVRx Inc (CVRX) Institutional Confidence

The article analyzes the institutional confidence in CVRx Inc (CVRX), revealing a current institutional shareholding score of 5.00, placing it 109th out of 203 in its industry. The institutional shareholding proportion decreased by 19.00% quarter-over-quarter to 65.53%. Bill Nygr

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 10:11
Source
TradingKey
Moomoo Direct company coverage

CVRx Inc (CVRX) Stock Forecast & Analyst Ratings

This article provides a stock forecast and analyst ratings for CVRx Inc (CVRX). It likely includes insights into the company's financial performance, market position, and future outlook based on expert analysis, offering guidance for potential investors or current shareholders.

Tone
Neutral 50/100
Event
Guidance
Published
25 Jun 2026 08:40
Source
Moomoo
TradingKey Direct company coverage

CVRx Inc (CVRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of CVRx Inc (CVRX), detailing its current price momentum score, support and resistance levels, and various technical indicators and moving averages. The analysis suggests the stock is currently trading between a resistance level of 6.00

Tone
Negative 30/100
Event
Market update
Published
18 Jun 2026 20:39
Source
TradingKey
TradingKey Direct company coverage

CVRx Inc (CVRX) Financial Health: Profitability & Balance Sheet Analysis

CVRx Inc (CVRX) currently holds a financial score of 6.70, placing it 140th out of 203 companies in the Healthcare Equipment & Supplies industry. The company's financial status is stable, though its operating efficiency is noted as low. In its latest quarter, CVRx Inc reported a

Tone
Positive 66/100
Event
Earnings
Published
18 Jun 2026 10:10
Source
TradingKey
TradingKey Direct company coverage

CVRx Inc (CVRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for CVRx Inc (CVRX), showing its revenue by region. As of the last update on April 6, CVRx Inc's total revenue was $51.88 million from the US and $4.77 million from Europe, making up 91.58% and 8.42% of its revenue respectively. The artic

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 00:41
Source
TradingKey
Moomoo Direct company coverage

Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating

Craig-Hallum has reiterated its Buy rating on CVRx Inc (CVRX.US). The article does not provide further details regarding the rationale behind this rating or any financial analysis.

Tone
Positive 70/100
Event
Analyst action
Published
10 Jun 2026 03:10
Source
Moomoo
Investing.com Direct company coverage

CVRx CFO Jared Oasheim to step down after decade with company

Jared Oasheim, CFO of CVRx, Inc. (NASDAQ:CVRX), will be stepping down from his position after a decade with the company to pursue other professional opportunities. Oasheim, who played a key role in the company's IPO and establishing its financial organization, will remain until a

Tone
Neutral 50/100
Event
Market update
Published
09 Jun 2026 14:39
Source
Investing.com
The Globe and Mail Direct company coverage

CVRx Announces Chief Financial Officer Transition

CVRx, Inc. (NASDAQ: CVRX) announced that Jared Oasheim, its Chief Financial Officer, will be stepping down to pursue other professional opportunities. Mr. Oasheim will remain with the company until a successor is appointed and act as an advisor until February 2027 to ensure a smo

Tone
Neutral 50/100
Event
Market update
Published
09 Jun 2026 11:38
Source
The Globe and Mail